Israel Englander Bio Rad Laboratories, Inc. Call Options Transaction History

Millennium Management LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$263.97 - $344.64 $263,970 - $344,640	-1,000 Reduced 33.33%	2,000 $669,000
Q2 2024 Aug 14, 2024	BUY	$268.26 - $339.48 $268,260 - $339,480	1,000 Added 50.0%	3,000 $819,000
Q1 2024 May 15, 2024	BUY	$304.11 - $351.99 $608,220 - $703,980	2,000 New	2,000 $691,000
Q1 2023 May 15, 2023	BUY	$418.69 - $503.0 $10.5 Million - $12.6 Million	25,000 New	25,000 $12 Million
Q3 2022 Nov 14, 2022	BUY	$412.59 - $563.26 $10.3 Million - $14.1 Million	25,000 New	25,000 $10.4 Million

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $7.97B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.